glp-1 agonists marketing strategies 2025 The effect on MedTech GLP-1 Agonists Market Report 2025-2033,
Description
Experience all the benefits of GLP-1 probiotics and making you pursue your wellness goals
By 2024, an estimated 12% of American adults reported taking a GLP-1 medication for diabetes, weight loss, or heart disease, according to data from the Kaiser Family Foundation
69: 11351143 [DOI] [PubMed] [Google Scholar] 114.Creutzfeldt W, Ebert R, Willms B, et al
How long can I stay on a GLP-1 medication
A study by Stafeev et al
Participants lost 16.7% of baseline weight over 64 weeks, matching clinical trial outcomes despite using half the typical drug dose
